Betmiga 25 mg

Betmiga 25 mg is a medicine authorised by Swissmedic under authorisation number 62755. The authorisation holder is Astellas Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 May 2014 and the authorisation is valid without a time limit. ATC code G04BD12 places the medicine in the group Urologicals.

  • Dispensing category B
  • Authorisation number 62755
  • ATC G04BD12
  • Synthetic medicines
Authorisation data
Authorisation number62755
NameBetmiga 25 mg
Full nameBetmiga 25 mg, Retardtabletten
Authorisation holderAstellas Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeG04BD12
First authorisation19 May 2014
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Betmiga 25 mg, RetardtablettenB19 May 2014
2Betmiga 50 mg, RetardtablettenB19 May 2014

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
230Tablette(n)G04BD1205.02.0.B
390Tablette(n)G04BD1205.02.0.B
530Tablette(n)G04BD1205.02.0.B
690Tablette(n)G04BD1205.02.0.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Betmiga 25 mg authorised in Switzerland?

Yes. Betmiga 25 mg is authorised by Swissmedic under authorisation number 62755, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Betmiga 25 mg have?

Betmiga 25 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Betmiga 25 mg?

The authorisation holder is Astellas Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com